✦ LIBER ✦

Current seroepidemiological status of hepatitis A with a comparison of antibody titers after infection and vaccination

✍ Scribed by Shigetoshi Fujiyama; Koichi Odoh; Izumi Kuramoto; Kyosuke Mizuno; Ryuichiro Tsurusaki; Tatsuo Sato

Book ID: 118567173
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 387 KB
Volume: 21
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(94)80113-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term follow-up of antibody titers a

Long-term follow-up of antibody titers after hepatitis A vaccination

✍ KURAMOTO, I; FUJIYAMA, S; ODOH, K; MIZUNO, K; SATO, T 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 368 KB

Time course of hepatitis A virus antibod

Time course of hepatitis A virus antibody titer after active and passive immunization

✍ Shigetoshi Fujiyama; Shiro Iino; Koichi Odoh; Shoji Kuzuhara; Hiroaki Watanabe; 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 640 KB

To investigate the antibody titer necessary to prevent hepatitis A virus infection, either 15 or 7.5 mg/kg of immune serum globulin was injected into 10 antihepatitis A virus negative volunteers and their serum antihepatitis A virus titers were observed for 28 wk. In addition, antibody titers were o

Affinity of anti-HBs antibody after hepa

Affinity of anti-HBs antibody after hepatitis B vaccination

✍ M. RADKOWSKI; T. LASKUS; A. GOCH; J. ŚLUSARCZYK 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 536 KB

Antibody titres after primary and booste

Antibody titres after primary and booster vaccination of infants and young children with a virosomal hepatitis A vaccine (Epaxal®)

✍ V. Usonis; V. Bakasénas; R. Valentelis; G. Katiliene; D. Vidzeniene; C. Herzog 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 68 KB

The use of dried blood spots for assessi

The use of dried blood spots for assessing antibody response to hepatitis A virus after natural infection and vaccination

✍ J.G. Melgaço; M.A. Pinto; A.M. Rocha; M. Freire; L.P. Gaspar; S.M.B. Lima; O.G. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB

## Abstract During recent years, vaccination against hepatitis A has been implemented in several countries. It is expected that the increase in mass vaccination against hepatitis A will eventually result in a decreased prevalence of anti‐HAV antibodies in the general population. For this reason, a

Characterization of a human monoclonal a

Characterization of a human monoclonal antibody obtained after immunization with plasma vaccine and a booster with recombinant-DNA hepatitis B vaccine

✍ R.A. Heijtink; J. Kruining; P. van Bergen; S. de Rave; J. van Hattum; M. Schutte 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

A human monoclonal antibody type IgG4, designated 1Ff4, was obtained by Epstein Barr virus transformation of peripheral blood lymphocytes from a hepatitis B vaccinee (HB-VAX: plasmaderived vaccine) after one boost of yeast recombinant DNA derived vaccine (Engerix-B). 1Ff4 binds preferentially to HBs